Sandoz Settles Texas Drug Inflation Claims For $66M
A Massachusetts federal judge on Tuesday tossed certain claims against Sandoz Inc. in a multidistrict litigation accusing pharmaceutical companies of reporting inflated drug values to Medicaid programs after the drugmaker settled...To view the full article, register now.
Already a subscriber? Click here to view full article